XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Bausch Health Companies Inc. Shareholders’ Deficit
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non- controlling Interest
Beginning Balance (in shares) at Dec. 31, 2021     359,400,000        
Beginning Balance at Dec. 31, 2021 $ (34) $ (106) $ 10,317 $ 462 $ (8,961) $ (1,924) $ 72
Increase (Decrease) in Shareholders' Equity              
Proceeds from B+L initial public offering, net of costs (Note 2) 675 (190)   (327)   137 865
Common shares issued under share-based compensation plans (in shares)     2,200,000        
Common shares issued under share-based compensation plans 3 3 $ 63 (60)      
Share-based compensation 58 58   58      
Employee withholding taxes related to share-based awards (29) (29)   (29)      
Net (loss) income (205) (214)     (214)   9
Other comprehensive income (loss) (215) (215)       (215)  
Ending Balance (in shares) at Jun. 30, 2022     361,600,000        
Ending Balance at Jun. 30, 2022 253 (693) $ 10,380 104 (9,175) (2,002) 946
Beginning Balance (in shares) at Mar. 31, 2022     361,300,000        
Beginning Balance at Mar. 31, 2022 (141) (216) $ 10,373 415 (9,030) (1,974) 75
Increase (Decrease) in Shareholders' Equity              
Proceeds from B+L initial public offering, net of costs (Note 2) 675 (190)   (327)   137 865
Common shares issued under share-based compensation plans (in shares)     300,000        
Common shares issued under share-based compensation plans 1 1 $ 7 (6)      
Share-based compensation 26 26   26      
Employee withholding taxes related to share-based awards (4) (4)   (4)      
Net (loss) income (139) (145)     (145)   6
Other comprehensive income (loss) (165) (165)       (165)  
Ending Balance (in shares) at Jun. 30, 2022     361,600,000        
Ending Balance at Jun. 30, 2022 $ 253 (693) $ 10,380 104 (9,175) (2,002) 946
Beginning Balance (in shares) at Dec. 31, 2022 361,898,846   361,900,000        
Beginning Balance at Dec. 31, 2022 $ 260 (692) $ 10,391 159 (9,186) (2,056) 952
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     2,100,000        
Common shares issued under share-based compensation plans 0   $ 21 (21)      
Share-based compensation 74 74   74      
Employee withholding taxes related to share-based awards (15) (15)   (15)      
Vesting of B+L equity compensation 0 (9)   (9)     9
Net (loss) income (182) (175)     (175)   (7)
Other comprehensive income (loss) $ 134 154       154 (20)
Ending Balance (in shares) at Jun. 30, 2023 364,063,514   364,000,000.0        
Ending Balance at Jun. 30, 2023 $ 271 (663) $ 10,412 188 (9,361) (1,902) 934
Beginning Balance (in shares) at Mar. 31, 2023     363,600,000        
Beginning Balance at Mar. 31, 2023 145 (800) $ 10,405 171 (9,387) (1,989) 945
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     400,000        
Common shares issued under share-based compensation plans 0   $ 7 (7)      
Share-based compensation 33 33   33      
Employee withholding taxes related to share-based awards (3) (3)   (3)      
Vesting of B+L equity compensation 0 (6)   (6)     6
Net (loss) income 27 26     26   1
Other comprehensive income (loss) $ 69 87       87 (18)
Ending Balance (in shares) at Jun. 30, 2023 364,063,514   364,000,000.0        
Ending Balance at Jun. 30, 2023 $ 271 $ (663) $ 10,412 $ 188 $ (9,361) $ (1,902) $ 934